期刊文献+

甲磺酸伊马替尼抑制博莱霉素诱导小鼠肺纤维化的作用机制

Imatinib mesylate inhibits bleomycin-induced pulmonary fibrosis in mice:the mechanism
在线阅读 下载PDF
导出
摘要 目的:观察甲磺酸伊马替尼(以下简称伊马替尼)对博莱霉素诱导的小鼠肺纤维化的干预作用,并探讨其可能的作用机制。方法:C57BL/6小鼠随机分为对照组、模型组、地塞米松组和伊马替尼组(n=30)。采用博莱霉素制备小鼠肺纤维化模型,分别于术后第7、14、21天各处死10只小鼠,免疫组化半定量分析各组肺组织转化生长因子β1(TGF-β1)、基质金属蛋白酶1(MMP-1)、基质金属蛋白酶抑制剂1(TIMP-1)表达的变化,并作相关性分析。结果:与模型组比较,伊马替尼组、地塞米松组肺组织TIMP-1、MMP-1、TGF-β1表达均降低(P<0.01)。TIMP-1表达与TGF-β1呈正相关(r=0.243,P=0.004);除正常对照组外,其余3组MMP-1表达与TIMP-1表达呈负相关(r=-0.291,P<0.0001)。结论:甲磺酸伊马替尼可能通过下调TGF-β1抑制TIMP-1表达,从而相对上调MMP-1,维持TIMP-1/MMP-1平衡,抑制博莱霉素诱导的小鼠肺纤维化,作用效果与地塞米松类似。 Objective:To observe the effect of imatinib mesytate on pulmonary fibrosis (PF) induced by bleomycin in mice and to explore the related mechanism. Methods: Totally 120 C57BL/6 mice were evenly randomized into control group, model group, dexamethasone group and imatinib group. The pulmonary fibrosis model was established using a single intratracheal infusion of bleomyein; the corresponding drugs were given to mice in each group. Ten mice was sacrificed in each group on day 7,14, and 21 after operation, respectively. The expression of matrix metalloproteinase 1 (MMP-1), tissue inhibitor of metalloproteinase 1 (TIMP-1), and transforming growth factor-β1 (TGF-β1) in the lung tissues was semi quantitatively analyzed by immunohlstochemistry method. Results: Immunohistochemistry results showed that the expression of TIMP-1, MMP-1, and TGF-β1 in lung tissues of the dexamethasone group and imatinib group was significantly lower than that in the model group(P〈0.01). There was a positive correlation between TGF- β1 and TIMP 1 expression(r=0. 243,P=0. 004). A negative correlation was found between MMP 1 and TIMP 1 in all the other 3 groups other than in the normal control group(r= -0. 291,P〈 0. 000 1). Conclusion: Imatinib may downregulate TGF-β1 expression, inhibit TIMP-1 expression, and upregulate MMP 1 expression, maintaining the balance of TIMP-1/MMP-1, subsequently inhibit the development of pulmonary fibrosis, showing a similar effect of dexamethasone.
作者 李莉 李燕芹
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第6期645-650,共6页 Academic Journal of Second Military Medical University
基金 上海市科委科研基金(06411963)~~
关键词 甲磺酸伊马替尼 博莱霉素 肺纤维化 转化生长因子β 基质金属蛋白酶1 基质金属蛋白酶抑制剂1 imatinib mesylate bleomycin pulmonary fibrosis transforming growth factor 13 matrix metalloproteinase 1 tissue inhibitors of metalloproteinase 1
  • 相关文献

参考文献13

  • 1Davies H R,Richeldi L.Idiopathic pulmonary fibrosis:current and future treatment options[J].Am J Respir Med,2002,1;211-224.
  • 2Snell G I,Walters E H,Kotsimbos T C,Williams T J.Idiopathic pulmonary fibrosis:in need of focused and systematic management[J].Med J Aust,2001,174:137-140.
  • 3Horowitz J C,Thannickal V J.Idiopathic pulmonary fibrosis:new concepts in pathogenesis and implications for drug therapy[J].Treat Respir Med,2006,5:325-342.
  • 4Rice A B,Moomaw C R,Morgan D L,Bonner J C.Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats[J].Am J Pathol,1999,155:213-221.
  • 5李莉,李燕芹.格列卫对博莱霉素致小鼠肺纤维化的干预作用[J].中国危重病急救医学,2007,19(4):229-232. 被引量:9
  • 6Kolb M,Margetts P J,Galt T,Sime P J,Xing Z,Sehmidt M,et al.Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin[J].Am J Respir Crit Care Med,2001,163(3 Pt 1):770-777.
  • 7Aono Y,Nishioka Y,Inayama M,Ugai M,Kishi J,Uehara H,et al.Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice[J].Am J Respir Crit Care Med,2005,171:1279-1285.
  • 8Dik W A,McAnuhy R J,Versnel M A,Naber B A,Zimmermann L J,Laurent G J,et al.Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats[J].Thorax,2003,58:765-771.
  • 9章巍,刘新民,李海潮,张红.博来霉素致大鼠肺纤维化模型肺组织MMP-2、MMP-9、MT1-MMP及TIMP-1、TIMP-2的表达[J].北京大学学报(医学版),2002,34(6):716-721. 被引量:25
  • 10黄山英,宋良文.效应细胞、细胞因子及相关基因调控在肺纤维化发生中的作用研究进展[J].国外医学(呼吸系统分册),2005,25(5):328-330. 被引量:11

二级参考文献37

  • 1李燕芹,吕寒冰,方马荣,刘斌,徐佳波.急性肺损伤时肺部纤维化及血管生成状态的研究[J].中国危重病急救医学,2004,16(11):677-678. 被引量:10
  • 2俞森洋.糖皮质激素在急性呼吸窘迫综合征治疗中的作用和评价[J].中国危重病急救医学,2005,17(6):321-322. 被引量:15
  • 3段斐,牛建昭,王继峰,杨美娟,赵丽云,王志刚.复方鳖甲片防治实验大鼠肺纤维化图像的分析[J].军医进修学院学报,2005,26(3). 被引量:2
  • 4黄山英,宋良文.效应细胞、细胞因子及相关基因调控在肺纤维化发生中的作用研究进展[J].国外医学(呼吸系统分册),2005,25(5):328-330. 被引量:11
  • 5Lemjabbar H, Gosset P, Lechapt-Zalcman E, et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment[J]. Am J Respir Cell Mol Biol, 1999, 20(5):903-913
  • 6Selman M, Ruiz V, Cabrera S, et al. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment[J]? Am J Physiol Lung Cell Mol Physiol, 2000, 279(3):L562-574
  • 7Corbel M, Caulet-Maugendre S, Germain N, et al. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrixmetalloproteinase inhibitor batimastat[J]. J Pathol, 2001,193(4):538-545
  • 8Suga M, Iyonaga K, Okamoto T, et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2000, 162(5):1949-1956
  • 9Phan SH.Role of the myofibroblast in pulmonary fibrosis.Kidney Int,1996,49(Suppl 54): S46-S48.
  • 10Zuo F,Kaminski N,Eugui E,et al.Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.Proc Natl Acad Sci USA,2002,99(9):6292-6297.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部